Russell D. Petty

Dundee, SCT, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 87 publications

Correction: Loss of the tumour suppressor LKB1/STK11 uncovers a leptin-mediated sensitivity mechanism to mitochondrial uncouplers for targeted cancer therapy.

Correction: Loss of the tumour suppressor LKB1/STK11 uncovers a leptin-mediated sensitivity mechanism to mitochondrial uncouplers for targeted cancer therapy.

Journal: Molecular cancer

Published: January 12, 2026

Correction: Relative telomere length and senescence-associated inflammatory cytokines as blood-based prognostic markers in patients with advanced or resectable gastro-oesophageal adenocarcinoma.

Correction: Relative telomere length and senescence-associated inflammatory cytokines as blood-based prognostic markers in patients with advanced or resectable gastro-oesophageal adenocarcinoma.

Journal: British journal of cancer

Published: December 19, 2025

Maintenance capecitabine after first-line platinum-based chemotherapy in advanced oesophagogastric adenocarcinoma: final analysis from the PLATFORM trial.

Maintenance capecitabine after first-line platinum-based chemotherapy in advanced oesophagogastric adenocarcinoma: final analysis from the PLATFORM trial.

Journal: British journal of cancer

Published: December 17, 2025

The density of tumour infiltrating lymphocytes in oesophago-gastric cancer varies with disease stage, geographical region and treatment: a post hoc analysis of nine phase III clinical trials.

The density of tumour infiltrating lymphocytes in oesophago-gastric cancer varies with disease stage, geographical region and treatment: a post hoc analysis of nine phase III clinical trials.

Journal: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association

Published: November 07, 2025

Quality Assurance in Multi-Modality Oesophago-Gastric Cancer Clinical Trials: Past, Present and Future Perspectives.

Quality Assurance in Multi-Modality Oesophago-Gastric Cancer Clinical Trials: Past, Present and Future Perspectives.

Journal: Clinical oncology (Royal College of Radiologists (Great Britain))

Published: October 08, 2025

Immune cell senescence drives responsiveness to immunotherapy in melanoma.

Immune cell senescence drives responsiveness to immunotherapy in melanoma.

Journal: Molecular cancer

Published: July 31, 2025

Research priorities for cancers of the oesophagus and stomach: recommendations from a UK and Ireland patient and healthcare professional partnership exercise.

Research priorities for cancers of the oesophagus and stomach: recommendations from a UK and Ireland patient and healthcare professional partnership exercise.

Journal: Gut

Published: July 14, 2025

Normothermic catheter-based intraperitoneal chemotherapy: Systematic review using the IDEAL framework.

Normothermic catheter-based intraperitoneal chemotherapy: Systematic review using the IDEAL framework.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Published: June 29, 2025

Germline Variants and Impact on Lung Cancer Outcomes Following Chemotherapy: A Systematic Review.

Germline Variants and Impact on Lung Cancer Outcomes Following Chemotherapy: A Systematic Review.

Journal: Critical reviews in oncology/hematology

Published: June 01, 2025

Interrogating the regulatory epigenome of cellular senescence.

Interrogating the regulatory epigenome of cellular senescence.

Journal: Cellular and molecular life sciences : CMLS

Published: April 22, 2025

Relative telomere length and senescence-associated inflammatory cytokines as blood-based prognostic markers in patients with advanced or resectable gastro-oesophageal adenocarcinoma.

Relative telomere length and senescence-associated inflammatory cytokines as blood-based prognostic markers in patients with advanced or resectable gastro-oesophageal adenocarcinoma.

Journal: British journal of cancer

Published: April 10, 2025

Trifluridine/tipiracil (FTD/TPI) in advanced gastric cancer-a retrospective cohort study providing real-world survival and safety data from the United Kingdom.

Trifluridine/tipiracil (FTD/TPI) in advanced gastric cancer-a retrospective cohort study providing real-world survival and safety data from the United Kingdom.

Journal: Journal of gastrointestinal oncology

Published: February 18, 2025

Showing 1-12 of 87

Last Updated: 09/26/2026